SeaSpine Revenue and Competitors

Location

$87.8M

Total Funding

Estimated Revenue & Valuation

  • SeaSpine's estimated annual revenue is currently $182.3M per year.(i)
  • SeaSpine's estimated revenue per employee is $369,028
  • SeaSpine's total funding is $87.8M.
  • SeaSpine's current valuation is $472.3M. (January 2022)

Employee Data

  • SeaSpine has 494 Employees.(i)
  • SeaSpine grew their employee count by -3% last year.

SeaSpine's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Area VP, SoutheastReveal Email/Phone
3
Executive Assistant to President and CEOReveal Email/Phone
4
Area VPReveal Email/Phone
5
VP Product Development, Spinal HardwareReveal Email/Phone
6
SVP, Global Spinal SystemsReveal Email/Phone
7
VP and GM, Biologics ManufacturingReveal Email/Phone
8
VP SalesReveal Email/Phone
9
VP Sales (East) - Enabling TechnologiesReveal Email/Phone
10
VP, Software Engineering - Enabling TechnologiesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is SeaSpine?

OUR MISSION Our SeaSpine family is dedicated to collaborating with surgeons to develop cost effective solutions to treat spinal disorders. We do this by providing high quality, differentiated and complementary technologies that leverage our core competencies in orthobiologics, interbody devices and modular spinal instrumentation systems. OUR VISION We seek to be a marketshare-taker by driving improved procedural solutions that combine efficient spinal instrumentation systems with industry leading orthobiologics to deliver clinical value to the surgeon, hospital and patient.

keywords:Healthcare,Medical Devices

$87.8M

Total Funding

494

Number of Employees

$182.3M

Revenue (est)

-3%

Employee Growth %

$472.3M

Valuation

N/A

Accelerator

SeaSpine News

2022-04-20 - SeaSpine (NASDAQ:SPNE) Earns Overweight Rating from ...

SeaSpine (NASDAQ:SPNE – Get Rating)'s stock had its “overweight” rating reissued by investment analysts at Cantor Fitzgerald in a research...

2022-04-19 - SeaSpine Holdings (SPNE) PT Lowered to $21 at Cantor ...

Cantor Fitzgerald analyst Brandon Folkes lowered the price target on SeaSpine Holdings (NASDAQ: SPNE) to $21.00 (from $27.00) while...

2022-04-06 - SeaSpine Announces Full Commercial Launch of the Reef ...

CARLSBAD, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$407.1M49410%N/A
#2
$134.5M52527%N/A
#3
N/A52724%N/A
#4
$195.8M540N/AN/A
#5
$155.2M5472%N/A